E-Paper
‘Encouraging results’: Delhi CM on plasma therapy trials for coronavirus
Delhi began plasma therapy trials for coronavirus disease patients on Tuesday, with two persons receiving the treatment that uses antibody-rich plasma (a blood component) taken from those who have recovered from the infection to treat critical patients.
The initial results of plasma therapy conducted on four Covid-19 patients in the city have given satisfactory results, Delhi chief minister Arvind Kejriwal said on Friday, adding that more such trials will be conducted in the next few days.
Delhi began plasma therapy trials for coronavirus disease patients on Tuesday. A treatment that uses antibody-rich plasma (a blood component) taken from those who have recovered from the infection to treat critical patients.
“In the last few days, we have tried plasma therapy on four patients at Lok Nayak Jai Prakash Narayan Hospital. Till now the results are encouraging,” said CM Kejriwal.
The CM added that the Centre has given permission for limited trials. He said his government will seek permission next week to use the therapy on all serious Covid-19 patients across the city.
Watch l ‘Plasma therapy trial on COVID-19 patients showing positive result’: Kejriwal
Kejriwal also appealed to those who have recovered from Covid-19 to come forward and donate plasma for serious patients.
The trials are being conducted in collaboration with the Institute of Liver and Biliary Sciences, which will be processing the blood to derive plasma and store it.
